Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium

NCT03476798 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer
Endometrial Cancer

Interventions

DRUG: Rucaparib
DRUG: Bevacizumab

Sponsor

University of Oklahoma

Collaborators

[object Object]